Form4insider filings, from the source

Company · CIK 0001583648 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

PALVELLA THERAPEUTICS, INC. · PVLA

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $4.9M · 3net −$4.9M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesAug 28Sep 2Sep 7Sep 12Sep 18Sep 23Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 SForm 4 →Sep 18, 4:05 pm EDTKathleen GoinChief Operating Officer4,302$152.24$654,9230−100%10b5-1
Sep 16, 2026 MForm 4 →Sep 18, 4:05 pm EDTKathleen GoinChief Operating Officer4,302$8.11$34,8834,302—10b5-1
Sep 11, 2026 SForm 4 →Sep 15, 9:15 pm EDTGeorge M JenkinsDirector27,500$151.53$4,167,146160,116−14.7%10b5-1
Sep 2, 2026 SForm 4 →Sep 4, 4:05 pm EDTChristopher P KiritsyDirector313$157.00$49,141250−55.6%
Sep 2, 2026 MForm 4 →Sep 4, 4:05 pm EDTChristopher P KiritsyDirector313$127.20$39,814563—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 MForm 4 →Sep 18, 4:05 pm EDTKathleen GoinChief Operating Officer4,302——2,148—10b5-1
Sep 2, 2026 MForm 4 →Sep 4, 4:05 pm EDTChristopher P KiritsyDirector313——0—